Simona Halep, a two-time Grand Slam champion and former top-ranked WTA participant, was given a second cost for doping, as reported by ESPN. This second infraction, as introduced by the Worldwide Tennis Integrity Company (ITIA), is “separate and along with” a provisional suspension she was given final summer time after failing a drug check through the U.S. Open.
Weeks after her first-round loss within the New York-hosted Grand Slam, the ITIA revealed a constructive check for roxadustat. Used to deal with anemia, roxadustat will increase purple blood cell manufacturing and has been notable as a efficiency enhancing drug in professional biking. The second cost, in accordance with the ITIA, comes from an extra overview of Halep’s organic passport profile.
Halep posted her response to the brand new cost on Twitter, stating that she has twice tried to have her case reviewed by an impartial panel just for the ITIA to postpone each makes an attempt.